Link Immunotherapeutics

Developer of immunotherapeutics to treat cancer

placeSeattle, Washington, United States calendar_todayFounded 2019 groups15 employees language linkimmunotherapeutics.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 51 times.

YearFilings
20231
20241

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon